Prazosin Alternatives for Night Terrors
Image rehearsal therapy (IRT) is the recommended first-line treatment for night terrors (nightmare disorder), with or without PTSD, and should be prioritized over prazosin or any pharmacologic alternative. 1
Non-Pharmacologic Alternatives (Preferred)
Primary Recommendation
IRT is the only treatment with a "recommended" designation from the American Academy of Sleep Medicine (AASM) for both PTSD-associated nightmares and nightmare disorder. 1 This cognitive behavioral therapy technique involves rewriting nightmare content with positive imagery and rehearsing the new scenario for 10-20 minutes daily while awake. Studies demonstrate sustained reduction in nightmare frequency from 3-4 nights per week to 1-2 nights per week at 6-month follow-up. 1
Additional Evidence-Based Options ("May Be Used")
The following non-pharmacologic treatments have AASM support for nightmare disorder 1:
- Exposure, relaxation, and rescripting therapy (ERRT) - Particularly effective in children and patients with comorbid bipolar disorder 2
- Cognitive behavioral therapy (CBT) and CBT for insomnia (CBT-I) - Combining CBT-I with IRT may improve outcomes 2
- Eye movement desensitization and reprocessing (EMDR) - For PTSD-associated nightmares
- Hypnosis
- Lucid dreaming therapy
- Progressive deep muscle relaxation
- Self-exposure therapy
- Systematic desensitization
Recent evidence suggests self-guided and brief treatment modalities offer efficient alternatives to traditional longer therapy courses. 3
Pharmacologic Alternatives
Alpha-1 Adrenergic Antagonists
Terazosin is the most logical pharmacologic alternative to prazosin, as it shares the same mechanism (selective α1-adrenergic antagonist). Case reports demonstrate effectiveness for trauma-related nightmares when prazosin fails. 4 This represents a straightforward substitution with similar dosing considerations.
Other Pharmacologic Options ("May Be Used")
The AASM position paper lists these medications for nightmare disorder 1:
For PTSD-associated nightmares:
- Atypical antipsychotics: Olanzapine, risperidone, aripiprazole (quetiapine also shows promise 5)
- Clonidine (another alpha-2 agonist)
- Cyproheptadine (antihistamine with antiserotonergic properties)
- Gabapentin
- Topiramate
- Trazodone
- Tricyclic antidepressants
- Fluvoxamine
- Phenelzine (MAOI)
- Nabilone (synthetic cannabinoid - emerging evidence from Canada) 2
For non-PTSD nightmare disorder:
- Nitrazepam
- Triazolam
Medications to AVOID
Clonazepam and venlafaxine are NOT recommended for nightmare disorder treatment. 1
Clinical Decision Algorithm
Step 1: Start with IRT as first-line treatment regardless of PTSD status. This has the strongest evidence and "recommended" designation.
Step 2: If psychotherapy is unavailable, refused, or insufficient:
- For PTSD-associated nightmares: Consider terazosin (if prazosin failed/contraindicated), clonidine, or atypical antipsychotics (risperidone, olanzapine)
- For non-PTSD nightmare disorder: Consider nitrazepam or triazolam
Step 3: Optimize outcomes by combining pharmacotherapy with psychotherapy. Patients showing greatest response to prazosin were typically receiving concurrent antidepressants (91%) and psychotherapy (61%). 6
Step 4: If nightmares persist, consider adjunctive agents like gabapentin, topiramate, or trazodone.
Important Caveats
Prazosin's evidence has weakened: Recent large trials led to downgrading by both AASM and VA/DoD guidelines. 2 However, it remains commonly prescribed due to lack of superior alternatives. The evidence for most pharmacologic alternatives is limited to "may be used" designation, indicating less clear evidence.
Combination therapy is superior: The highest response rates occur when medications are combined with psychotherapy and antidepressants. 6 Don't rely on monotherapy.
Novel agents under investigation include ramelteon, cannabinoids, ketamine, and psychedelic agents, but lack sufficient evidence for routine use. 5
Monitor for adverse effects: Alpha-blockers can cause orthostatic hypotension and dizziness. 1 Atypical antipsychotics carry metabolic risks. Benzodiazepines and sedative-hypnotics lack efficacy evidence and carry dependence risks.
The evidence strongly favors starting with IRT over any pharmacologic intervention, including prazosin, for both efficacy and safety profile. 1, 3